Related references
Note: Only part of the references are listed.Huntingtin Aggregation Kinetics and Their Pathological Role in a Drosophila Huntington's Disease Model
Kurt R. Weiss et al.
GENETICS (2012)
Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment
Jun Wu et al.
CHEMISTRY & BIOLOGY (2011)
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
Susanna Campesan et al.
CURRENT BIOLOGY (2011)
Aging causes distinct characteristics of polyglutamine amyloids in vivo
Ayako Tonoki et al.
GENES TO CELLS (2011)
High-Content Chemical and RNAi Screens for Suppressors of Neurotoxicity in a Huntington's Disease Model
Joost Schulte et al.
PLOS ONE (2011)
A Genomewide RNA Interference Screen for Modifiers of Aggregates Formation by Mutant Huntingtin in Drosophila
Sheng Zhang et al.
GENETICS (2010)
Refinement of Tools for Targeted Gene Expression in Drosophila
Barret D. Pfeiffer et al.
GENETICS (2010)
Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis
Kristina Becanovic et al.
HUMAN MOLECULAR GENETICS (2010)
Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis
Surendra S. Ambegaokar et al.
NEUROBIOLOGY OF DISEASE (2010)
Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model
Sheng Zhang et al.
DISEASE MODELS & MECHANISMS (2009)
Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models
Takuya Tamura et al.
PLOS ONE (2009)
RNAi Screening in Drosophila Cells Identifies New Modifiers of Mutant Huntingtin Aggregation
Joanna Doumanis et al.
PLOS ONE (2009)
Huntington's disease: the case for genetic modifiers
James F. Gusella et al.
GENOME MEDICINE (2009)
Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds
Javier Gayan et al.
GENETIC EPIDEMIOLOGY (2008)
Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes
Michele Markstein et al.
NATURE GENETICS (2008)
Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm
Eliana Romero et al.
NEURON (2008)
The commonly used marker ELAV is transiently expressed in neuroblasts and glial cells in the Drosophila embryonic CNS
Christian Berger et al.
DEVELOPMENTAL DYNAMICS (2007)
Alteration of Drosophila life span using conditional, tissue-specific expression of transgenes triggered by doxycyline or RU486/Mifepristone
Daniel Ford et al.
EXPERIMENTAL GERONTOLOGY (2007)
Huntingtin interacting proteins are genetic modifiers of neurodegeneration
Linda S. Kaltenbach et al.
PLOS GENETICS (2007)
Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24:: the HD MAPS study
Jian-Liang Li et al.
BMC MEDICAL GENETICS (2006)
Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Construction of transgenic Drosophila by using the site-specific integrase from phage φC31
AC Groth et al.
GENETICS (2004)
Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease
WCM Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A cell-based screen for drugs to treat Huntington's disease
CT Aiken et al.
NEUROBIOLOGY OF DISEASE (2004)
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein
S Willingham et al.
SCIENCE (2003)
Fly models of Huntington's disease
JL Marsh et al.
HUMAN MOLECULAR GENETICS (2003)
A genome scan for modifiers of age at onset in Huntington disease:: The HD MAPS study
JL Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila
BL Apostol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1
P Kazemi-Esfarjani et al.
HUMAN MOLECULAR GENETICS (2002)
GAL4 system in Drosophila:: A fly geneticist's Swiss army knife
JB Duffy
GENESIS (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Tetracycline-inducible systems for Drosophila
MJ Stebbins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Genetic suppression of polyglutamine toxicity in Drosophila
P Kazemi-Esfarjani et al.
SCIENCE (2000)
Atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain
BA Hassan et al.
NEURON (2000)
Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila
JL Marsh et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
